penmix 30 flexpen
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride - treatment of diabetes mellitus.
penmix 30 innolet
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.
actrapid
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.
actrapid penfill
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.
actrapid flexpen
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.
actrapid innolet
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.
mixtard 30
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.
penmix 30 penfill
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride, approx - treatment of diabetes mellitus.
penmix 40 penfill
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 60 iu/ml; ; neutral insulin, human, pyr 40 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 60 iu/ml neutral insulin, human, pyr 40 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride, approx. - treatment of diabetes mellitus.
penmix 50 penfill
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 50 iu/ml; ; neutral insulin, human, pyr 50 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 50 iu/ml neutral insulin, human, pyr 50 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride, approx. - treatment of diabetes mellitus.